Q: Is that for people on GLP-1s specifically
It is contraindicated with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
After four weeks, the dose is increased to 5 mg weekly, which represents the first maintenance dose for glycemic control
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity
In a late-stage trial, participants lost an average of 11.2% of their body weight
(4) The whole process is only deprotected in the last step, and frequent deprotection is not needed, so that racemization of amino acid and introduction of other impurities are not basically caused